Samuel J Rubin

Title: Samuel J Rubin: Innovator in Blood-Based Diagnostics

Introduction

Samuel J Rubin is a notable inventor based in Stanford, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in the analysis of inflammatory bowel disease (IBD). His innovative approach focuses on utilizing blood-based signatures for diagnosis and sub-typing of IBD subsets.

Latest Patents

Samuel J Rubin holds a patent for a method that analyzes peripheral blood leukocytes. The patent, titled "Blood-based signatures for diagnosis and sub-typing of inflammatory bowel disease subsets," outlines a process that includes labeling peripheral blood leukocytes isolated from patients suspected of having IBD with a panel of distinguishably-labeled antibodies. The method involves analyzing the binding of these antibodies to the leukocytes, which can aid in diagnosing conditions such as Crohn's disease or ulcerative colitis. He has 1 patent to his name.

Career Highlights

Samuel J Rubin is affiliated with Leland Stanford Junior University, where he continues to advance research in the medical field. His work has garnered attention for its potential to improve diagnostic accuracy and patient outcomes in IBD.

Collaborations

One of his notable collaborators is Aida Habtezion, with whom he has worked on various research initiatives aimed at enhancing understanding and treatment of inflammatory bowel diseases.

Conclusion

Samuel J Rubin's contributions to blood-based diagnostics represent a significant advancement in the medical field. His innovative methods have the potential to transform how inflammatory bowel diseases are diagnosed and managed.